LGC launches SARS-CoV-2 molecular solution for Oral Fluid Testing

News (ZH) - Product designed to support development and testing efforts around novel saliva-based SARS-CoV-2 diagnostics

LGC’s ValuPanel Reagents help public laboratories detect SARS-CoV-2 and influenza

News (ZH) - Research use only reagents allows detection of SARS-CoV-2, influenza A, and influenza B from a single patient sample

LGC launches SARS-CoV-2 quality solution for antigen testing

News (ZH) - Formulated for use with test methods that detect nucleocapsid protein of SARS-CoV-2 virus

LGC’s high-throughput PCR testing system for SARS-CoV-2 detection granted Emergency Use Authorisation

News (ZH) - Authorisation enables qualified laboratories to address SARS-CoV-2 testing demands while providing significant economic advantage when compared to other technologies

Mike Rogers awarded MBE in Queen’s Birthday Honours List 2021

News (ZH) - Assistant Director in LGC's Grant Management Group awarded MBE for services to Covid-19 Research Funding

TNAC wins Best COVID-19 Responder award

News (ZH) - Awarded for efforts in supporting research and development of diagnostics and vaccines for COVID-19

LGC’s ultra-high throughput Nexar™ technology provides significant PCR testing capacity at Rosalind Franklin Laboratory

News (ZH) - Ultra-high throughput technology enables large-scale PCR testing in reposnse to global pandemic

LGC launches SARS-CoV-2 Delta Variant quality solution

News (ZH) - Safe, non-infectious, and replication deficient quality solution for Delta variant detection and analysis

Measurement science improves standardisation of SARS-CoV-2 quantification

News (ZH) - NML team analysis vital to understanding potential discrepancies in measured viral burden used to manage CoVid-19 pandemic

LGC, Biosearch Technologies testing workflow underpins expansion of COVID-19 testing in New York

News (ZH) - Nexar workflow continues to enable simple, scalable, and cost-effective testing